Targeting intrinsic apoptosis and other forms of cell death by BH3-mimetics in glioblastoma
出版年份 2017 全文链接
标题
Targeting intrinsic apoptosis and other forms of cell death by BH3-mimetics in glioblastoma
作者
关键词
-
出版物
Expert Opinion on Drug Discovery
Volume 12, Issue 10, Pages 1031-1040
出版商
Informa UK Limited
发表日期
2017-07-17
DOI
10.1080/17460441.2017.1356286
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- BH3-mimetics and BET-inhibitors elicit enhanced lethality in malignant glioma
- (2017) Chiaki Tsuge Ishida et al. Oncotarget
- Mitochondrial matrix chaperone and c-myc inhibition causes enhanced lethality in glioblastoma
- (2017) Chiaki Tsuge Ishida et al. Oncotarget
- A Synthetic Cell-Penetrating Dominant-Negative ATF5 Peptide Exerts Anticancer Activity against a Broad Spectrum of Treatment-Resistant Cancers
- (2016) G. Karpel-Massler et al. CLINICAL CANCER RESEARCH
- OTX015 (MK-8628), a novel BET inhibitor, displaysin vitroandin vivoantitumor effects alone and in combination with conventional therapies in glioblastoma models
- (2016) Caroline Berenguer-Daizé et al. INTERNATIONAL JOURNAL OF CANCER
- BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer
- (2016) I. A. Asangani et al. MOLECULAR CANCER RESEARCH
- Interference with the HSF1/HSP70/BAG3 Pathway Primes Glioma Cells to Matrix Detachment and BH3 Mimetic–Induced Apoptosis
- (2016) Patrick Antonietti et al. MOLECULAR CANCER THERAPEUTICS
- Venetoclax Approved for CLL
- (2016) Cancer Discovery
- Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax
- (2016) Joan Montero et al. Cancer Discovery
- Metabolic reprogramming of glioblastoma cells by L-asparaginase sensitizes for apoptosis in vitro and in vivo
- (2016) Georg Karpel-Massler et al. Oncotarget
- Inhibition of deubiquitinases primes glioblastoma cells to apoptosis in vitro and in vivo
- (2016) Georg Karpel-Massler et al. Oncotarget
- Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study
- (2016) Sandy Amorim et al. Lancet Haematology
- Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition
- (2015) A. Henssen et al. CLINICAL CANCER RESEARCH
- Bcl2L12 with a BH3-like domain in regulating apoptosis and TMZ-induced autophagy: A prospective combination of ABT-737 and TMZ for treating glioma
- (2015) MING-CHANG YANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Toward precision medicine in glioblastoma: the promise and the challenges
- (2015) Michael D. Prados et al. NEURO-ONCOLOGY
- Assessment of ABT-263 activity across a cancer cell line collection leads to a potent combination therapy for small-cell lung cancer
- (2015) Anthony C. Faber et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)
- (2015) J D Leverson et al. Cell Death & Disease
- Combined inhibition of Bcl-2/Bcl-xL and Usp9X/Bag3 overcomes apoptotic resistance in glioblastoma in vitro and in vivo
- (2015) Georg Karpel-Massler et al. Oncotarget
- TIC10/ONC201 synergizes with Bcl-2/Bcl-xL inhibition in glioblastoma by suppression of Mcl-1 and its binding partners in vitro and in vivo
- (2015) Georg Karpel-Massler et al. Oncotarget
- Sorafenib Sensitizes Glioma Cells to the BH3 Mimetic ABT-737 by Targeting MCL1 in a STAT3-Dependent Manner
- (2015) Irina Kiprianova et al. NEOPLASIA
- PI3K and Bcl-2 Inhibition Primes Glioblastoma Cells to Apoptosis through Downregulation of Mcl-1 and Phospho-BAD
- (2014) Fresia Pareja et al. MOLECULAR CANCER RESEARCH
- Usp9x- and Noxa-mediated Mcl-1 downregulation contributes to pemetrexed-induced apoptosis in human non-small-cell lung cancer cells
- (2014) J Yan et al. Cell Death & Disease
- Obatoclax (GX15-070) triggers necroptosis by promoting the assembly of the necrosome on autophagosomal membranes
- (2013) F Basit et al. CELL DEATH AND DIFFERENTIATION
- YM-155 Potentiates the Effect of ABT-737 in Malignant Human Glioma Cells via Survivin and Mcl-1 Downregulation in an EGFR-Dependent Context
- (2013) E. P. Jane et al. MOLECULAR CANCER THERAPEUTICS
- Structure-guided design of a selective BCL-XL inhibitor
- (2013) Guillaume Lessene et al. Nature Chemical Biology
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- OBATOCLAX and ABT-737 Induce ER Stress Responses in Human Melanoma Cells that Limit Induction of Apoptosis
- (2013) David Wroblewski et al. PLoS One
- Dual Inactivation of Akt and ERK by TIC10 Signals Foxo3a Nuclear Translocation, TRAIL Gene Induction, and Potent Antitumor Effects
- (2013) J. E. Allen et al. Science Translational Medicine
- p53-dependent regulation of Mcl-1 contributes to synergistic cell death by ionizing radiation and the Bcl-2/Bcl-XL inhibitor ABT-737
- (2011) Katrin E. Tagscherer et al. APOPTOSIS
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- HSP70 Protein Promotes Survival of C6 and U87 Glioma Cells by Inhibition of ATF5 Degradation
- (2011) Guangfu Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Multiple BH3 Mimetics Antagonize Antiapoptotic MCL1 Protein by Inducing the Endoplasmic Reticulum Stress Response and Up-regulating BH3-only Protein NOXA
- (2011) Tina C. Albershardt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
- (2011) Johannes Zuber et al. NATURE
- The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation
- (2010) Jiangbin Ye et al. EMBO JOURNAL
- The Pan-Bcl-2 Inhibitor (-)-Gossypol Triggers Autophagic Cell Death in Malignant Glioma
- (2010) V. Voss et al. MOLECULAR CANCER RESEARCH
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications
- (2010) Zhi Sheng et al. NATURE MEDICINE
- Obatoclax induces Atg7-dependent autophagy independent of beclin-1 and BAX/BAK
- (2010) F McCoy et al. Cell Death & Disease
- Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
- (2009) Martin Schwickart et al. NATURE
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
- (2008) C. Tse et al. CANCER RESEARCH
- Discovery of ABT-263, a Bcl-family protein inhibitor: observations on targeting a large protein–protein interaction
- (2008) Michael D Wendt Expert Opinion on Drug Discovery
- Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins
- (2008) K E Tagscherer et al. ONCOGENE
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search